Over the past two decades it has been shown that, in addition to erythropoietic activity, erythropoietin (EPO) has numerous other functions, including neuro-protective, anti-apoptotic, antioxidant, angiogenic and immunomodulatory functions. EPO action is expressed through the interaction with two different forms of its receptor (EPOR): a homodimeric, responsible for the erythropoietic effects, and a heterodimeric one, responsible for the non-erythropoietic effects. Stimulation of this latter receptor has also been shown to be effective in prolonging organ transplant survival, both in murine models and in humans. The development of new molecules that act selectively on heterodimeric EPOR, devoid of erythropoietic activity, has allowed to begin to evaluate the effect of long-term treatments, avoiding the possible complications, mainly of a cardiovascular nature, linked to the increase in the hematocrit.

Chiara Guglielmo, C.C. (2019). ERitropoietina, ormone tuttofare. GIORNALE ITALIANO DI NEFROLOGIA, 5(4), 1-12.

ERitropoietina, ormone tuttofare

Chiara Guglielmo;Paola Todeschini;
2019

Abstract

Over the past two decades it has been shown that, in addition to erythropoietic activity, erythropoietin (EPO) has numerous other functions, including neuro-protective, anti-apoptotic, antioxidant, angiogenic and immunomodulatory functions. EPO action is expressed through the interaction with two different forms of its receptor (EPOR): a homodimeric, responsible for the erythropoietic effects, and a heterodimeric one, responsible for the non-erythropoietic effects. Stimulation of this latter receptor has also been shown to be effective in prolonging organ transplant survival, both in murine models and in humans. The development of new molecules that act selectively on heterodimeric EPOR, devoid of erythropoietic activity, has allowed to begin to evaluate the effect of long-term treatments, avoiding the possible complications, mainly of a cardiovascular nature, linked to the increase in the hematocrit.
2019
Chiara Guglielmo, C.C. (2019). ERitropoietina, ormone tuttofare. GIORNALE ITALIANO DI NEFROLOGIA, 5(4), 1-12.
Chiara Guglielmo, Chiara Cantarelli, Andrea Angeletti, Paola Todeschini, Paolo Cravedi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/700343
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact